Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 WHO issues guidelines on HCV amid drug cost controversy.

× No keyword cloud information.

7 in total

Review 1. Hepatitis C virus: A time for decisions. Who should be treated and when?

Authors: Bashar M Attar; David H Van Thiel
Journal: World J Gastrointest Pharmacol Ther Date: 2016-02-06

2. DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.

Authors: Jing Ying Zhang; Zhi Bin Li; Lei Zhang; Jun Wang; Le Ping Huang; Gui Lai Zhan; Zhu Li; Jiang Du; Min Zhao
Journal: BMC Infect Dis Date: 2019-09-05 Impact factor: 3.090

3. Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.

Authors: Chen Yang; Xinhao Zhao; Dakang Sun; Leilei Yang; Chang Chong; Yu Pan; Xiumei Chi; Yanhang Gao; Moli Wang; Xiaodong Shi; Haibo Sun; Juan Lv; Yuanda Gao; Jin Zhong; Junqi Niu; Bing Sun
Journal: Cell Mol Immunol Date: 2015-02-16 Impact factor: 11.530

7. The reduction of miR146b-5p in monocytes and T cells could contribute to the immunopathogenesis of hepatitis C virus infection.

Authors: Yasuteru Kondo; Takayuki Kogure; Masashi Ninomiya; Ryo Fukuda; Norikazu Monma; Kazuho Ikeo; Yasuhito Tanaka
Journal: Sci Rep Date: 2019-09-16 Impact factor: 4.379

7 in total

WHO issues guidelines on HCV amid drug cost controversy.

Review 1. Hepatitis C virus: A time for decisions. Who should be treated and when?

2. DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.

3. Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.

Review 4. A New Twist to a Chronic HCV Infection: Occult Hepatitis C.

5. Conditional Inducible Triple-Transgenic Mouse Model for Rapid Real-Time Detection of HCV NS3/4A Protease Activity.

6. AMPK: a novel target for treating hepatic fibrosis.

7. The reduction of miR146b-5p in monocytes and T cells could contribute to the immunopathogenesis of hepatitis C virus infection.